Sequential Intravesical Gemcitabine and Docetaxel for the Salvage Treatment of Non-Muscle Invasive Bladder Cancer

BACKGROUND: Bacillus Calmette-Guerin (BCG) is the most effective intravesical therapy for non-muscle invasive bladder cancer (NMIBC), but patients can fail or supply shortages can develop. For BCG failures, radical cystectomy is recommended. However, in patients who desire bladder preservation or ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinberg, Ryan L., Thomas, Lewis J., O’Donnell, Michael A., Nepple, Kenneth G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2015
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218180/
https://www.ncbi.nlm.nih.gov/pubmed/30561441
http://dx.doi.org/10.3233/BLC-150008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218180/
https://www.ncbi.nlm.nih.gov/pubmed/30561441
http://dx.doi.org/10.3233/BLC-150008

Ejemplares similares